Israel Englander Amneal Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 817,584 shares of AMRX stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

817,584

Previous 930,567 12.14%

Holding current value

$7.01 Million

Previous $5.91 Million 15.11%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $725,350 - $997,639	-112,983 Reduced 12.14%	817,584 $6.8 Million
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $2.37 Million - $3.15 Million	442,932 Added 90.83%	930,567 $5.91 Million
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $2.56 Million - $3.09 Million	487,635 New	487,635 $2.96 Million
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $2.75 Million - $6.4 Million	-2,065,044 Reduced 66.75%	1,028,641 $3.19 Million
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $2.44 Million - $5.18 Million	-1,919,693 Reduced 38.29%	3,093,685 $4.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $5.95 Million - $7.92 Million	3,034,426 Added 153.33%	5,013,378 $9.98 Million
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $2.16 Million - $3.88 Million	1,070,673 Added 117.88%	1,978,952 $4 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $2.32 Million - $3.44 Million	772,235 Added 567.64%	908,279 $2.89 Million
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $4.35 Million - $5.45 Million	-1,114,158 Reduced 89.12%	136,044 $567,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $1.47 Million - $2.18 Million	372,898 Added 42.5%	1,250,202 $5.99 Million
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $232,912 - $304,785	54,040 Added 6.56%	877,304 $4.69 Million
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $2.89 Million - $3.85 Million	565,132 Added 218.93%	823,264 $4.22 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $1.22 Million - $1.91 Million	258,132 New	258,132 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $276,867 - $379,904	-70,093 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $171,704 - $255,616	-48,504 Reduced 40.9%	70,093 $272,000
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $340,373 - $647,539	118,597 New	118,597 $565,000
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $4.23 Million - $9.2 Million	-1,719,817 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $2.57 Million - $5.4 Million	971,365 Added 129.78%	1,719,817 $8.29 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $294,299 - $912,456	128,515 Added 20.73%	748,452 $2.17 Million
Q2 2019 Aug 15, 2019	BUY	$6.44 - $14.29 $2.32 Million - $5.14 Million	359,816 Added 138.33%	619,937 $4.45 Million
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $1.32 Million - $2.93 Million	204,923 Added 371.25%	260,121 $19.9 Million
Q1 2019 May 14, 2019	BUY	$11.87 - $14.84 $655,200 - $819,138	55,198 New	55,198 $782,000
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $1.84 Million - $3.02 Million	-140,567 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $25.4 Million - $37.7 Million	-1,551,688 Reduced 91.69%	140,567 $3.12 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $23.6 Million - $34.2 Million	1,692,255 New	1,692,255 $27.8 Million

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.3B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account